BioTel Research Blog

Ed Ashton, Ph.D.

Ed Ashton, Ph.D.
Edward Ashton serves as the Vice President of Oncology Imaging for BioTel Research. In this role, he has provided technical leadership on more than 100 clinical trials in oncology and neurology over the past fifteen years. Dr. Ashton is a frequent speaker at international imaging conferences, and has authored many peer-reviewed publications describing his research. Prior to joining BioTel Research, Dr. Ashton was a lead signal processing engineer at The MITRE Corporation in McLean, VA. Earlier in his career, he spent three years as a research engineer with the Naval Research Laboratory, where he received the Alan Berman Research Publication Award and was nominated for the Edison Award for Applied Science. Dr. Ashton has produced numerous articles on target detection and image analysis with military applications. He received both his Ph.D. and M.S. degrees in electrical engineering from the University of Rochester, and his B.S. degree in electrical engineering from Loyola College.
Find me on:


Progress in Immune-Oncology Imaging

The advent of immune checkpoint inhibition and other immune-related therapies has produced a sea change in the treatment of a wide range of oncology indications. The impact of these new treatment [...]

April 22, 2019


Response Assessment in Immune-Oncology

Seven years after the approval of the first immune checkpoint inhibitor for the treatment of metastatic melanoma, immunotherapy remains one of the primary areas of focus for oncology drug [...]

March 13, 2018


Immunotherapy Promises and Pitfalls

Just after the new year, I was fortunate enough to attend the Immunotherapy World Conference in Miami, Florida, where I was invited to participate in a panel with a few sponsors, including Aron [...]

March 09, 2017

BioTel Research, One Preserve Parkway, Suite #600, Rockville, MD 20852